Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese Mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 1, 2016, Pages 78-85

  Xia, Ning ^a   Horke, Sven ^a   Habermeier, Alice ^a   Closs, Ellen I ^a   Reifenberg, Gisela ^a   Gericke, Adrian ^a   Mikhed, Yuliya ^a   Münzel, Thomas ^a,b   Daiber, Andreas ^a,b   Förstermann, Ulrich ^a   Li, Huige ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

eNOS uncoupling; nitric oxide; obesity; perivascular adipose tissue; vascular function

Indexed keywords

ADIPONECTIN; ARGINASE; ARGININE; CD68 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOCYTOKINE; AUTACOID; CYTOKINE; ENZYME INHIBITOR; NOS3 PROTEIN, MOUSE; VASODILATOR AGENT;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; MALE; MOUSE; NONHUMAN; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VASCULAR DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; LIPID DIET; METABOLISM; OBESITY; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; THORACIC AORTA; VASODILATATION;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; AORTA, THORACIC; ARGINASE; ARGININE; CYTOKINES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INFLAMMATION MEDIATORS; MALE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PARACRINE COMMUNICATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 84952638318     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306263     Document Type: Article

References (45)

1. Rooney K, Ozanne SE, Maternal over-nutrition and offspring obesity predisposition: targets for preventative interventions. Int J Obes (Lond) 2011 35 883 890. doi: 10.1038/ijo.2011.96
2. Flegal KM, Kit BK, Orpana H, Graubard BI, Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013 309 71 82. doi: 10.1001/jama.2012.113905
3. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB, Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008 117 1658 1667. doi: 10.1161/CIRCULATIONAHA.107.739714
4. Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT, Tschöp MH, Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 2012 92 1479 1514. doi: 10.1152/physrev.00022.2011
5. Lavie CJ, Milani RV, Ventura HO, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009 53 1925 1932. doi: 10.1016/j.jacc.2008.12.068
6. Schillaci G, Pirro M, Vaudo G, Mannarino MR, Savarese G, Pucci G, Franklin SS, Mannarino E, Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 2005 45 1078 1082. doi: 10.1161/01.HYP.0000165313.84007.7d
7. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM, Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009 119 1661 1670. doi: 10.1161/CIRCULATIONAHA.108.821181
8. Li H, Forstermann U, Pharmacological prevention of eNOS uncoupling. Curr Pharm Des 2014 20 3595 3606
9. Li H, Förstermann U, Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol 2013 13 161 167. doi: 10.1016/j.coph.2013.01.006
10. Tian XY, Wong WT, Xu A, Lu Y, Zhang Y, Wang L, Cheang WS, Wang Y, Yao X, Huang Y, Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res 2012 110 1211 1216. doi: 10.1161/CIRCRESAHA.111.262170
11. Cheang WS, Tian XY, Wong WT, Lau CW, Lee SS, Chen ZY, Yao X, Wang N, Huang Y, Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway. Arterioscler Thromb Vasc Biol 2014 34 830 836. doi: 10.1161/ATVBAHA.113.301938
12. Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, Vetter W, Barton M, Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 2002 20 2239 2245
13. Soltis EE, Cassis LA, Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 1991 13 277 296
14. Szasz T, Webb RC, Perivascular adipose tissue: more than just structural support. Clin Sci (Lond) 2012 122 1 12. doi: 10.1042/CS20110151
15. Gollasch M, Vasodilator signals from perivascular adipose tissue. Br J Pharmacol 2012 165 633 642. doi: 10.1111/j.1476-5381.2011.01430.x
16. Ribiere C, Jaubert AM, Gaudiot N, Sabourault D, Marcus ML, Boucher JL, Denis-Henriot D, Giudicelli Y, White adipose tissue nitric oxide synthase: a potential source for NO production. Biochem Biophys Res Commun 1996 222 706 712. doi: 10.1006/bbrc.1996.0824
17. Elizalde M, Rydén M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, Ramel S, Olund A, Arner P, Andersson K, Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 2000 41 1244 1251
18. Dashwood MR, Dooley A, Shi-Wen X, Abraham DJ, Souza DS, Does periadventitial fat-derived nitric oxide play a role in improved saphenous vein graft patency in patients undergoing coronary artery bypass surgery? J Vasc Res 2007 44 175 181. doi: 10.1159/000099833
19. Mastronardi CA, Yu WH, McCann SM, Resting and circadian release of nitric oxide is controlled by leptin in male rats. Proc Natl Acad Sci USA 2002 99 5721 5726. doi: 10.1073/pnas.082098499
20. Gil-Ortega M, Stucchi P, Guzmán-Ruiz R, Cano V, Arribas S, González MC, Ruiz-Gayo M, Fernández-Alfonso MS, Somoza B, Adaptative nitric oxide overproduction in perivascular adipose tissue during early diet-induced obesity. Endocrinology 2010 151 3299 3306. doi: 10.1210/en.2009-1464
21. Förstermann U, Münzel T, Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006 113 1708 1714. doi: 10.1161/CIRCULATIONAHA.105.602532
22. Li H, Horke S, Förstermann U, Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 2013 34 313 319. doi: 10.1016/j.tips.2013.03.007
23. Münzel T, Daiber A, Ullrich V, Mülsch A, Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 2005 25 1551 1557. doi: 10.1161/01.ATV.0000168896.64927.bb
24. Zou MH, Shi C, Cohen RA, Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 2002 109 817 826. doi: 10.1172/JCI14442
25. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG, Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001 103 1282 1288
26. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T, Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008 10 1115 1126. doi: 10.1089/ars.2007.1989
27. Yang Z, Ming XF, Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol 2013 4 149. doi: 10.3389/fimmu.2013.00149
28. Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB, Caldwell RW, Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol 2012 165 506 519. doi: 10.1111/j.1476-5381.2011.01584.x
29. Pernow J, Jung C, Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 2013 98 334 343. doi: 10.1093/cvr/cvt036
30. Shatanawi A, Romero MJ, Iddings JA, Chandra S, Umapathy NS, Verin AD, Caldwell RB, Caldwell RW, Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. Am J Physiol Cell Physiol 2011 300 C1181 C1192. doi: 10.1152/ajpcell.00328.2010
31. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, Caldwell RB, Caldwell RW, Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008 102 95 102. doi: 10.1161/CIRCRESAHA.107.155028
32. Ming XF, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, Hayoz D, Ruffieux J, Rusconi S, Montani JP, Yang Z, Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 2004 110 3708 3714. doi: 10.1161/01.CIR.0000142867.26182.32
33. Ryoo S, Lemmon CA, Soucy KG, Gupta G, White AR, Nyhan D, Shoukas A, Romer LH, Berkowitz DE, Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res 2006 99 951 960. doi: 10.1161/01.RES.0000247034.24662.b4
34. Molica F, Morel S, Kwak BR, Rohner-Jeanrenaud F, Steffens S, Adipokines at the crossroad between obesity and cardiovascular disease. Thromb Haemost 2015 113 553 566. doi: 10.1160/TH14-06-0513
35. Almabrouk TA, Ewart MA, Salt IP, Kennedy S, Perivascular fat, AMP-activated protein kinase and vascular diseases. Br J Pharmacol 2014 171 595 617. doi: 10.1111/bph.12479
36. Gil-Ortega M, Condezo-Hoyos L, García-Prieto CF, Arribas SM, González MC, Aranguez I, Ruiz-Gayo M, Somoza B, Fernández-Alfonso MS, Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat diet-derived endothelial dysfunction. PLoS One 2014 9 e95312. doi: 10.1371/journal.pone.0095312
37. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006 116 1494 1505. doi: 10.1172/JCI26498
38. Ponnuswamy P, Schröttle A, Ostermeier E, Grüner S, Huang PL, Ertl G, Hoffmann U, Nieswandt B, Kuhlencordt PJ, eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 2012 7 e30193. doi: 10.1371/journal.pone.0030193
39. Heiss EH, Dirsch VM, Regulation of eNOS enzyme activity by posttranslational modification. Curr Pharm Des 2014 20 3503 3513
40. Dudzinski DM, Michel T, Life history of eNOS: partners and pathways. Cardiovasc Res 2007 75 247 260. doi: 10.1016/j.cardiores.2007.03.023
41. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL, Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 2014 34 1631 1636. doi: 10.1161/ATVBAHA.114.303030
42. Holowatz LA, Thompson CS, Kenney WL, L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J Physiol 2006 574 pt 2 573 581. doi: 10.1113/jphysiol.2006.108993
43. Shemyakin A, Kövamees O, Rafnsson A, Böhm F, Svenarud P, Settergren M, Jung C, Pernow J, Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus. Circulation 2012 126 2943 2950. doi: 10.1161/CIRCULATIONAHA.112.140335
44. Quitter F, Figulla HR, Ferrari M, Pernow J, Jung C, Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion. Clin Hemorheol Microcirc 2013 54 75 85. doi: 10.3233/CH-2012-1617
45. Holowatz LA, Kenney WL, Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans. J Physiol 2007 581 pt 2 863 872. doi: 10.1113/jphysiol.2007.128959